Perkutane bildgeführte Radiofrequenzablation von Nierentumoren: Update 2015

BackgroundStage I renal cell carcinoma is a malignancy with a relatively good prognosis. The incidence of all renal cell carcinomas is approximately 9/100,000 persons. There are nearly 15,000 newly diagnosed patients every year (men twice as often as women).TrendIn the last decade, a trend away from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Sommer, Christof-Matthias (VerfasserIn) , Stampfl, Ulrike (VerfasserIn) , Kauczor, Hans-Ulrich (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Veröffentlicht: 22. Februar 2015
In: Der Urologe
Year: 2015, Jahrgang: 54, Heft: 2, Pages: 219-230
DOI:10.1007/s00120-014-3672-4
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00120-014-3672-4
Verlag, Volltext: https://link.springer.com/article/10.1007/s00120-014-3672-4
Volltext
Verfasserangaben:C.M. Sommer, U. Stampfl, H.U. Kauczor, P.L. Pereira

MARC

LEADER 00000caa a2200000 c 4500
001 1560407212
003 DE-627
005 20221117134743.0
007 cr uuu---uuuuu
008 170703s2015 xx |||||o 00| ||ger c
024 7 |a 10.1007/s00120-014-3672-4  |2 doi 
035 |a (DE-627)1560407212 
035 |a (DE-576)490407218 
035 |a (DE-599)BSZ490407218 
035 |a (OCoLC)1340976528 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a ger 
084 |a 33  |2 sdnb 
100 1 |a Sommer, Christof-Matthias  |d 1978-  |e VerfasserIn  |0 (DE-588)133929701  |0 (DE-627)558738699  |0 (DE-576)278278035  |4 aut 
245 1 0 |a Perkutane bildgeführte Radiofrequenzablation von Nierentumoren  |b Update 2015  |c C.M. Sommer, U. Stampfl, H.U. Kauczor, P.L. Pereira 
246 3 0 |a Percutaneous radiofrequency ablation of renal tumors$dupdate 2015 
264 1 |c 22. Februar 2015 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.07.2017 
520 |a BackgroundStage I renal cell carcinoma is a malignancy with a relatively good prognosis. The incidence of all renal cell carcinomas is approximately 9/100,000 persons. There are nearly 15,000 newly diagnosed patients every year (men twice as often as women).TrendIn the last decade, a trend away from radical open resection towards nephron-sparing approaches has been observed. Currently, partial nephrectomy is the surgical gold standard for the treatment of small renal tumors. However, excellent clinical results are obtained using percutaneous radiofrequency ablation (RFA): low complication rates and preservation of the renal function.ResultsPrimary and secondary technical success rates are 69-100% and 90-100%, respectively. In large series, major complication rates of RFA of 0-14% are reported. A relevant deterioration of renal function after RFA is very rare. The 5-year local recurrence-free survival rates, metastasis-free survival rates, cancer-specific survival rates, and overall survival rates are 88-93, 95-100, 98-100, and 58.3-85%, respectively. In this context, the lack of appropriate long-term data is often cited as a limitation.ConclusionDifferent meta-analyses come to the conclusion that in case of adequate tumor and patient selection RFA shows oncologic results comparable with surgical resection. Accepted indications for RFA are T1 renal tumors in patients with advanced age, significant comorbidities, reduced renal function, single kidney, and/or no wish for operation. Predictors for the success include tumor size and location as well as operator experience. To define the real efficacy of RFA in the treatment of renal tumors, randomized controlled clinical long-term studies are indicated. 
700 1 |a Stampfl, Ulrike  |d 1978-  |e VerfasserIn  |0 (DE-588)132557711  |0 (DE-627)523645104  |0 (DE-576)261999664  |4 aut 
700 1 |a Kauczor, Hans-Ulrich  |d 1962-  |e VerfasserIn  |0 (DE-588)139267123  |0 (DE-627)70327113X  |0 (DE-576)310955327  |4 aut 
773 0 8 |i Enthalten in  |t Der Urologe  |d [Berlin : Springer Medizin, 2005  |g 54(2015), 2, Seite 219-230  |h Online-Ressource  |w (DE-627)101704192X  |w (DE-600)2925337-8  |w (DE-576)501620842  |7 nnas  |a Perkutane bildgeführte Radiofrequenzablation von Nierentumoren Update 2015 
773 1 8 |g volume:54  |g year:2015  |g number:2  |g pages:219-230  |g extent:12  |a Perkutane bildgeführte Radiofrequenzablation von Nierentumoren Update 2015 
856 4 0 |u http://dx.doi.org/10.1007/s00120-014-3672-4  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s00120-014-3672-4  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170703 
993 |a Article 
994 |a 2015 
998 |g 139267123  |a Kauczor, Hans-Ulrich  |m 139267123:Kauczor, Hans-Ulrich  |d 910000  |d 911400  |e 910000PK139267123  |e 911400PK139267123  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 132557711  |a Stampfl, Ulrike  |m 132557711:Stampfl, Ulrike  |d 910000  |d 911400  |e 910000PS132557711  |e 911400PS132557711  |k 0/910000/  |k 1/910000/911400/  |p 2 
998 |g 133929701  |a Sommer, Christof-Matthias  |m 133929701:Sommer, Christof-Matthias  |d 910000  |d 911400  |e 910000PS133929701  |e 911400PS133929701  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1560407212  |e 2973071488 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1560407212"],"doi":["10.1007/s00120-014-3672-4"]},"name":{"displayForm":["C.M. Sommer, U. Stampfl, H.U. Kauczor, P.L. Pereira"]},"title":[{"title_sort":"Perkutane bildgeführte Radiofrequenzablation von Nierentumoren","title":"Perkutane bildgeführte Radiofrequenzablation von Nierentumoren","subtitle":"Update 2015"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["ger"],"note":["Gesehen am 03.07.2017"],"origin":[{"dateIssuedDisp":"22. Februar 2015","dateIssuedKey":"2015"}],"person":[{"display":"Sommer, Christof-Matthias","role":"aut","given":"Christof-Matthias","family":"Sommer"},{"family":"Stampfl","given":"Ulrike","role":"aut","display":"Stampfl, Ulrike"},{"display":"Kauczor, Hans-Ulrich","family":"Kauczor","given":"Hans-Ulrich","role":"aut"}],"relHost":[{"disp":"Perkutane bildgeführte Radiofrequenzablation von Nierentumoren Update 2015Der Urologe","physDesc":[{"extent":"Online-Ressource"}],"recId":"101704192X","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["ger"],"note":["Gesehen am 05.07.2022"],"title":[{"title_sort":"Urologe","title":"Der Urologe"}],"origin":[{"dateIssuedDisp":"[2005-2022]","publisherPlace":"[Berlin ; Heidelberg ; New York]","publisher":"Springer Medizin"}],"id":{"zdb":["2925337-8"],"eki":["101704192X"]},"part":{"volume":"54","year":"2015","issue":"2","text":"54(2015), 2, Seite 219-230","extent":"12","pages":"219-230"},"corporate":[{"display":"Deutsche Gesellschaft für Urologie","role":"isb"}],"name":{"displayForm":["Deutsche Gesellschaft für Urologie"]},"pubHistory":["Volume 44, issue 7 (July 2005)-volume 61, issue 5 (May 2022)"]}],"recId":"1560407212","physDesc":[{"extent":"12 S."}]} 
SRT |a SOMMERCHRIPERKUTANEB2220